Wallerian degeneration refers to a loss of the distal part of an axon after nerve injury. Wallerian degeneration slow (Wlds) mice overexpress a chimeric protein containing the NAD synthase NMNAT (nicotinamide mononucleotide adenylyltransferase 1) and exhibit a delay in axonal degeneration. Currently, conflicting evidence raises questions as to whether NMNAT is the protecting factor and whether its enzymatic activity is required for such a possible function. Importantly, the link between nmnat and axon degeneration is at present solely based on overexpression studies of enzymatically active protein. Here we use the visual system of Drosophila as a model system to address these issues. We have isolated the first nmnat mutations in a multicellular organism in a forward genetic screen for synapse malfunction in Drosophila. Loss of nmnat causes a rapid and severe neurodegeneration that can be attenuated by blocking neuronal activity. Furthermore, in vivo neuronal expression of mutated nmnat shows that enzymatically inactive NMNAT protein retains strong neuroprotective effects and rescues the degeneration phenotype caused by loss of nmnat. Our data indicate an NAD-independent requirement of NMNAT for maintaining neuronal integrity that can be exploited to protect neurons from neuronal activity-induced degeneration by overexpression of the protein.
References
[1]
Waller A (1850) Experiments on the section of the glossopharyngeal and hyoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philos Trans R Soc 140: 423–429.
[2]
Gillingwater TH, Ribchester RR (2001) Compartmental neurodegeneration and synaptic plasticity in the WldS mutant mouse. J Physiol 534: 627–639.
[3]
Zhai Q, Wang J, Kim A, Liu Q, Watts R, et al. (2003) Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 39: 217–225.
[4]
Finn JT, Weil M, Archer F, Siman R, Srinivasan A, et al. (2000) Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci 20: 1333–1341.
[5]
Sagot Y, Dubois-Dauphin M, Tan SA, de Bilbao F, Aebischer P, et al. (1995) Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci 15: 7727–7733.
[6]
Whitmore AV, Lindsten T, Raff MC, Thompson CB (2003) The proapoptotic proteins Bax and Bak are not involved in Wallerian degeneration. Cell Death Differ 10: 260–261.
[7]
Ludwin SK, Bisby MA (1992) Delayed wallerian degeneration in the central nervous system of Ola mice: an ultrastructural study. J Neurol Sci 109: 140–147.
[8]
Lunn ER, Perry VH, Brown MC, Rosen H, Gordon S (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1: 27–33.
[9]
Perry VH, Brown MC, Lunn ER (1991) Very slow retrograde and Wallerian degeneration in the CNS of C57BL/Ola mice. Eur J Neurosci 3: 102–105.
[10]
Ribchester RR, Tsao JW, Barry JA, Asgari-Jirhandeh N, Perry VH, et al. (1995) Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS). Eur J Neurosci 7: 1641–1650.
[11]
Conforti L, Tarlton A, Mack TG, Mi W, Buckmaster EA, et al. (2000) A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A 97: 11377–11382.
[12]
Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, et al. (2001) Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4: 1199–1206.
[13]
Adalbert R, Gillingwater TH, Haley JE, Bridge K, Beirowski B, et al. (2005) A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses. Eur J Neurosci 21: 271–277.
[14]
Hoopfer ED, McLaughlin T, Watts RJ, Schuldiner O, O'Leary DD, et al. (2006) WldS protection distinguishes axon degeneration following injury from naturally occurring developmental pruning. Neuron 50: 883–895.
Conforti L, Fang G, Beirowski B, Wang MS, Sorci L, et al. (2006) NAD+ and axon degeneration revisited: Nmnat1 cannot substitute for WldS to delay Wallerian degeneration. Cell Death Differ. doi: 10.1038/sj.cdd.4401944.
[17]
Fang C, Bernardes-Silva M, Coleman MP, Perry VH (2005) The cellular distribution of the WldS chimeric protein and its constituent proteins in the CNS. Neuroscience 135: 1107–1118.
[18]
MacDonald JM, Beach MG, Porpiglia E, Sheehan AE, Watts RJ, et al. (2006) The Drosophila cell corpse engulfment receptor draper mediates glial clearance of severed axons. Neuron 50: 869–881.
[19]
Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305: 1010–1013.
[20]
Laser H, Conforti L, Morreale G, Mack TG, Heyer M, et al. (2006) The slow Wallerian degeneration protein, WldS, binds directly to VCP/p97 and partially redistributes it within the nucleus. Mol Biol Cell 17: 1075–1084.
[21]
Wang J, Zhai Q, Chen Y, Lin E, Gu W, et al. (2005) A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 170: 349–355.
[22]
Mehta SQ, Hiesinger PR, Beronja S, Zhai RG, Schulze KL, et al. (2005) Mutations in Drosophila sec15 reveal a function in neuronal targeting for a subset of exocyst components. Neuron 46: 219–232.
[23]
Hiesinger PR, Fayyazuddin A, Mehta SQ, Rosenmund T, Schulze KL, et al. (2005) The v-ATPase V0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell 121: 607–620.
[24]
Verstreken P, Koh TW, Schulze KL, Zhai RG, Hiesinger PR, et al. (2003) Synaptojanin is recruited by Endophilin to promote synaptic vesicle uncoating. Neuron 40: 733–748.
[25]
Newsome TP, Asling B, Dickson BJ (2000) Analysis of Drosophila photoreceptor axon guidance in eye-specific mosaics. Development 127: 851–860.
[26]
Benzer S (1967) Behavioral mutants of Drosophila isolated by countercurrent distribution. Proc Natl Acad Sci U S A 58: 1112–1119.
[27]
Meinertzhagen IA, Hanson TE (1993) The development of the optic lobe. In: Martinez-Arias MBaA, editor. The development of Drosophila melanogaster. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press. pp. 1363–1491.
[28]
Hiesinger PR, Zhai RG, Zhou Y, Koh TW, Mehta SQ, et al. (2006) Activity-independent pre-specification of synaptic partmers in the visual map of Drosophila. Curr Biol 16: 1835–1843.
[29]
Zhai RG, Bellen HJ (2004) The architecture of the active zone in the presynaptic nerve terminal. Physiology (Bethesda) 19: 262–270.
[30]
Zhai RG, Hiesinger PR, Koh TW, Verstreken P, Schulze KL, et al. (2003) Mapping Drosophila mutations with molecularly defined P element insertions. Proc Natl Acad Sci U S A 100: 10860–10865.
[31]
Bellen HJ, Levis RW, Liao G, He Y, Carlson JW, et al. (2004) The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genes. Genetics 167: 761–781.
[32]
Emanuelli M, Carnevali F, Saccucci F, Pierella F, Amici A, et al. (2001) Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J Biol Chem 276: 406–412.
[33]
Raffaelli N, Sorci L, Amici A, Emanuelli M, Mazzola F, et al. (2002) Identification of a novel human nicotinamide mononucleotide adenylyltransferase. Biochem Biophys Res Commun 297: 835–840.
[34]
Schweiger M, Hennig K, Lerner F, Niere M, Hirsch-Kauffmann M, et al. (2001) Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett 492: 95–100.
[35]
Zhang X, Kurnasov OV, Karthikeyan S, Grishin NV, Osterman AL, et al. (2003) Structural characterization of a human cytosolic NMN/NaMN adenylyltransferase and implication in human NAD biosynthesis. J Biol Chem 278: 13503–13511.
[36]
Hotta Y, Benzer S (1970) Genetic dissection of the Drosophila nervous system by means of mosaics. Proc Natl Acad Sci U S A 67: 1156–1163.
[37]
Matsumoto E, Hirosawa K, Takagawa K, Hotta Y (1988) Structure of retinular cells in a visual mutant, rdgA, at early stages of degeneration. Cell Tissue Res 252: 293–300.
[38]
Raghu P, Usher K, Jonas S, Chyb S, Polyanovsky A, et al. (2000) Constitutive activity of the light-sensitive channels TRP and TRPL in the Drosophila diacylglycerol kinase mutant, rdgA. Neuron 26: 169–179.
[39]
Yoon J, Ben-Ami HC, Hong YS, Park S, Strong LL, et al. (2000) Novel mechanism of massive photoreceptor degeneration caused by mutations in the trp gene of Drosophila. J Neurosci 20: 649–659.
[40]
Wolff T, Ready DF (1993) Pattern formation in the Drosophila retina. In: Bate M, Martinez-Arias A, editors. The development of Drosophila melanogaster. Cold Spring Harbor (New York): Cold Spring Harbor Laboratory Press. pp. 1277–1325.
[41]
Bentrop J (1998) Rhodopsin mutations as the cause of retinal degeneration. Classification of degeneration phenotypes in the model system . Acta Anat (Basel) 162: 85–94.
[42]
Ranganathan R, Malicki DM, Zuker CS (1995) Signal transduction in Drosophila photoreceptors. Annu Rev Neurosci 18: 283–317.
[43]
Bloomquist BT, Shortridge RD, Schneuwly S, Perdew M, Montell C, et al. (1988) Isolation of a putative phospholipase C gene of Drosophila, norpA, and its role in phototransduction. Cell 54: 723–733.
[44]
McKay RR, Chen DM, Miller K, Kim S, Stark WS, et al. (1995) Phospholipase C rescues visual defect in norpA mutant of . J Biol Chem 270: 13271–13276.
[45]
Shieh BH, Zhu MY, Lee JK, Kelly IM, Bahiraei F (1997) Association of INAD with NORPA is essential for controlled activation and deactivation of Drosophila phototransduction in vivo. Proc Natl Acad Sci U S A 94: 12682–12687.
[46]
Hay BA, Wolff T, Rubin GM (1994) Expression of baculovirus P35 prevents cell death in Drosophila. Development 120: 2121–2129.
[47]
Masai I, Okazaki A, Hosoya T, Hotta Y (1993) Drosophila retinal degeneration A gene encodes an eye-specific diacylglycerol kinase with cysteine-rich zinc-finger motifs and ankyrin repeats. Proc Natl Acad Sci U S A 90: 11157–11161.
[48]
Georgiev P, Garcia-Murillas I, Ulahannan D, Hardie RC, Raghu P (2005) Functional INAD complexes are required to mediate degeneration in photoreceptors of the Drosophila rdgA mutant. J Cell Sci 118: 1373–1384.
[49]
Montell C (2005) TRP channels in Drosophila photoreceptor cells. J Physiol 567: 45–51.
[50]
Lee SJ, Montell C (2004) Suppression of constant-light-induced blindness but not retinal degeneration by inhibition of the rhodopsin degradation pathway. Curr Biol 14: 2076–2085.
[51]
Jacobson SG, McInnes RR (2002) Blinded by the light. Nat Genet 32: 215–216.
[52]
Noell WK, Walker VS, Kang BS, Berman S (1966) Retinal damage by light in rats. Invest Ophthalmol 5: 450–473.
[53]
Rongvaux A, Andris F, Van Gool F, Leo O (2003) Reconstructing eukaryotic NAD metabolism. Bioessays 25: 683–690.
[54]
Jellinger KA (2000) Cell death mechanisms in Parkinson's disease. J Neural Transm 107: 1–29.
[55]
Chung KK, Dawson VL, Dawson TM (2001) The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci 24: S7–14.
[56]
Imai Y, Soda M, Takahashi R (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J Biol Chem 275: 35661–35664.
[57]
Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, et al. (1999) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 23: 47–51.
[58]
Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL, et al. (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 23: 425–428.
[59]
Cummings CJ, Sun Y, Opal P, Antalffy B, Mestril R, et al. (2001) Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet 10: 1511–1518.
[60]
Bonini NM (2002) Chaperoning brain degeneration. Proc Natl Acad Sci U S A 99(Suppl 4): 16407–16411.
[61]
Tsuda H, Jafar-Nejad H, Patel AJ, Sun Y, Chen HK, et al. (2005) The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell 122: 633–644.
[62]
Balducci E, Emanuelli M, Raffaelli N, Ruggieri S, Amici A, et al. (1995) Assay methods for nicotinamide mononucleotide adenylyltransferase of wide applicability. Anal Biochem 228: 64–68.
[63]
Lee T, Luo L (2001) Mosaic analysis with a repressible cell marker (MARCM) for Drosophila neural development. Trends Neurosci 24: 251–254.
